For 14 years, we’ve united some of the most knowledgeable experts across pharma, biotech, CDMOs, generics, and regulatory bodies who are all keen to shape the future of high potency drugs. In pursuit of CMC excellence in oncology and other therapeutic areas requiring high potency compounds, we’re taking on a strategic approach this year to tackle the challenges that surround manufacturing safety, regulatory compliance, and innovation in drug development and delivery to seek incredible outcomes.